Skip to main content

Table 1 The clinicopathological relevance analysis of miR-1825 expression in GBM patients

From: Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway

Characteristics Cases miR-1825 P value
High Low
Age (years)     0.761
 ≥ 60 25 9 16  
 < 60 30 12 18  
Gender     0.399
 Male 35 12 23  
 Female 20 10 12  
WHO grade     0.022*
 I + II 20 12 8  
 III + IV 35 10 25  
Location     0.425
 Supratentorial 30 14 16  
 Subtentorial 25 9 16  
  1. Statistical analyses were performed by the χ2 test
  2. *P < 0.05 was considered significant